EX-32.1 4 sbph-ex321_7.htm EX-32.1 sbph-ex321_7.htm

 

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Spring Bank Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: October 28, 2016

By:

/s/ Martin Driscoll

 

 

Martin Driscoll

Chief Executive officer

 

 

(Principal Executive Officer)

 

 

 

 

By:

/s/ Jonathan Freve

 

 

Jonathan Freve

Chief Financial Officer, Treasurer and Secretary

 

 

(Principal Financial and Accounting Officer)